MRI Interventions: Volume Flowing In With A Potentially Revolutionary Technology

Jul. 03, 2012 9:46 AM ETClearPoint Neuro, Inc. (CLPT)BSX, SIEGY
VFC's Stock House profile picture
VFC's Stock House

MRI Interventions (MRIC.OB) has become a hot stock to watch lately as investors have clued in on the company's potential to become a major player in the trend toward more non-invasive surgical procedures. The company already has a foothold in the sector with an FDA-cleared medical device, ClearPoint, which is already "used to perform minimally invasive surgical procedures in the brain guided by intraoperative MR imaging," according to the company's website and other publicly available information.

The advance of MRI's technology allows the medical profession to more accurately and less invasively deliver therapies to treat a range of neurological diseases and disorders. What is key about the less invasive nature of the technology is the reductions in monetary resources and man-hours that may now be attributed to associated procedures, which is not a point to ignore as the enormous costs of health care have again dominated the political spotlight over recent weeks.

It's also noteworthy that MRIC's technology utilizes a hospital's already existing MRI suite, a huge convenience when bringing in an augmenting technology. MRI Interventions is also developing ClearTrace, a technology similar to ClearPoint, which would allow the company to infiltrate the market of less invasive heart care, as well.

Holding to the technology to potentially revolutionize heart and brain surgery at a time when the wheels are trending toward less invasive surgical corridors, MRIC is positioned to quickly become a "next generation" company that is gaining traction now.

As noted over the weekend, volume has been pouring in over the past few trading sessions in relative terms to the weeks and months prior, and the most recent volume influx has fueled a double in share price in just under two weeks time. Another 9% jump on Monday was also accompanied by record volume for this stock, which only became public months ago. Another key

This article was written by

VFC's Stock House profile picture
VFC is just a guy with an opinion. VFC's Stock House brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - the biotech, pharmaceutical and healthcare sectors. VFC's Stock House provides research, informational and opinion-based coverage of various companies and stocks in multiple sectors. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies. Do not Buy/Sell based solely on VFC's ideas or opinions. The goal of VFC's Stock House is to 'call it like I see it' - while bringing new ideas, companies, and discussions to the eyes of investors and readers. This is supposed to be fun and new investors should not invest with the idea that this will 'pay the bills' or with the belief that a stock will just keep going up. DD is paramount, but so is sticking to pre-conceived entry and exit strategies and not letting emotional trading get in the way. Goals must be realistic, if it sounds far fetched, then it probably is. Let the big boys eat the cake - the small investor is just trying to pick up some crumbs, and there's nothing wrong with that!

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.